Fluvastatin Sodium
規格
93957-55-2CAS番号
630-467-1EC番号
sodium (E,3S,5R)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoateIUPAC名
C24H25FNNaO4化学式
433.4 g/mol分子量
FLUVASTATIN SODIUM; 93957-55-2; Fractal; Lipaxan; Lymetel; Locol; Fluvastatin sodium salt; Fluindostatin; Primesin; Lescol; Vastin; Canef; Lescol XL; Cranoc; Almastatin; Primexin; PYF7O1FV7F; Lochol; XU 62-320; DTXSID3044758; XU-62-320; DTXCID5065306; Pinmactil; Luvinsta xl; Nandovar xl; Stefluvin xl; Dorisin xl; Fluvastatin Sodium ER; RefChem:56569; CHEBI:5137; XU62320; XU 62 320; 94061-81-1; sodium (3S,5R,E)-7-(3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl)-3,5-dihydroxyhept-6-enoate; (3S,5R)-FLUVASTATIN SODIUM SALT; (3S,5R)-fluvastatin sodium; (-)-3s,5r-fluvastatin sodium salt; MFCD00929076; (3S,5R)-Fluvastatin (sodium); sodium;(E,3S,5R)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoate; (3R,5S,6E)-rel-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid monosodium salt; rel-(3S,5R,E)-7-(3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl)-3,5-dihydroxyhept-6-enoic acid, sodium salt; Fluvastatin Sanabo; (3s,5r)-7-(3-(4-fluorophenyl)-1-isopropyl-1h-indol-2-yl)-3,5-dihydroxyhept-6-enoic acidsodium salt; Rel-Sodium (3S,5R,E)-7-(3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl)-3,5-dihydroxyhept-6-enoate; C24H25FNNaO4; UNII-PYF7O1FV7F; Fluvastatin sodium [USAN]; Fluindostatin;; CCRIS 6848; Primesin;; Fractal;; Lipaxan;; Lymetel;; Fluvastatin sodium [USAN:USP]; Cranoc;; Lescol;; Canef;; Locol;; Lescol (TN); (-)-fluvastatin sodium; BDS32J3EZK; SCHEMBL41663; MLS002154037; ARD193813Na; Fluvastatin sodium (JAN/USP); 3S,5R-Fluvastatin sodium salt; CHEMBL241778; orb1223582; orb1710566; FLUVASTATIN SODIUM [JAN]; CHEBI:77603; Fluvastatin sodium, (3S,5R)-; FLUVASTATIN SODIUM [VANDF]; GLXC-08139; HMS2097L19; HMS3067L20; HMS3714L19; FLUVASTATIN SODIUM [MART.]; (-)-(3S,5R)-fluvastatin sodium; (3S,5R)-(-)-fluvastatin sodium; (3S,5R)-7-(3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl)-3,5-dihydroxyhept-6-enoic acid sodium salt; FLUVASTATIN SODIUM [USP-RS]; FLUVASTATIN SODIUM [WHO-DD]; FLUVASTATIN SODIUM SALT [MI]; HY-14664C; AKOS015894901; CCG-220859; EBC-110059; FLUVASTATIN SODIUM [ORANGE BOOK]; FLUVASTATIN SODIUM [EP MONOGRAPH]; FLUVASTATIN SODIUM [USP IMPURITY]; FLUVASTATIN SODIUM [USP MONOGRAPH]; SMR000705060; Sodium (+-)-(3R*,5S*,6E)-7-(3-(p-fluorophenyl)-1-isopropylindol-2-yl)-3,5-dihydroxy-6-heptenoate; (3S,5R)-XU 62-320; CS-0019898; F0820; F4482; D00892; T10129; Q27147205; Fluvastatin sodium, European Pharmacopoeia (EP) Reference Standard; Fluvastatin sodium, United States Pharmacopeia (USP) Reference Standard; Fluvastatin for system suitability, European Pharmacopoeia (EP) Reference Standard; Fluvastatin sodium, Pharmaceutical Secondary Standard; Certified Reference Material; (+/-)-(3R*,5S*,6E)-7-(3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl)-3,5-dihydroxyhept-6-enoic acid, sodium salt; (3S,5R)-rel-7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid sodium salt; 6-Heptenoic acid, 7-(3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-3,5-dihydroxy-, monosodium salt, (R*,S*-(E))-(+-)-; 6-HEPTENOIC ACID, 7-(3-(4-FLUOROPHENYL)-1-(1-METHYLETHYL)-1H-INDOL-2-YL)-3,5-DIHYDROXY-, MONOSODIUM SALT, (R*,S*-(E))-(+/-)-; 6-Heptenoic acid, 7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-, monosodium salt, (3S,5R,6E)-; 6-Heptenoic acid, 7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-, monosodium salt, [R-[R*,S*-(E)]]-; 6-Heptenoic acid, 7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-, sodium salt (1:1), (3S,5R,6E)-; SODIUM (+/-)-(3R*,5S*,6E)-7-(3-(P-FLUOROPHENYL)-1-ISOPROPYLINDOL-2-YL)-3,5-DIHYDROXY-6-HEPTENOATE; sodium (3S,5R,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoate; sodium (3S,5R,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoate; sodium, (e)-(3s,5r)-7-[3-(4-fluoro-phenyl)-1-isopropyl-1h-indol-2-yl]-3,5-dihydroxy-hept-6-enoate; sodium;(E,3S,5R)-7-[3-(4-fluorophenyl)-1-isopropyl-indol-2-yl]-3,5-dihydroxy-hept-6-enoate別名
Fluvastatin Sodiumを含む製品
레스콜엑스엘서방정(플루바스타틴나트륨)フルバスタチン錠10mg「NIG」/フルバスタチン錠20mg「NIG」/フルバスタチン錠30mg「NIG」フルバスタチン錠10mg「サワイ」/フルバスタチン錠20mg「サワイ」/フルバスタチン錠30mg「サワイ」ローコール錠10mg/ローコール錠20mg/ローコール錠30mgFLUVASTATINA VIATRIS 80 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFGFLUVASTATINA VIATRIS 40 MG CAPSULAS DURAS EFGFLUVASTATINA VIATRIS 20 MG CAPSULAS DURAS EFGFLUVASTATINA TEVA-RATIOPHARM 80 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFGFLUVASTATINA TEVA 40 mg CAPSULAS DURAS EFGFLUVASTATINA TEVA 20 mg CAPSULAS DURAS EFGFLUVASTATINA RATIOPHARM 80 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFGFLUVASTATINA QUALIGEN 80 mg COMPRIMIDO DE LIBERACION PROLONGADA EFG
1/4ページ
Fluvastatin Sodiumを販売する企業
NA
Novartis AGSwitzerlandHF
HUNAN FURUI BIOPHARMA TECHNOLOGY CO., LTD.ChinaTP
Teva Pharma S.L.U.SpainVS
VIATRIS SANTEFranceSF
Sandoz Farmaceutica S.A.Spain1/2ページ